| Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine GD Sanders, PJ Neumann, A Basu, DW Brock, D Feeny, M Krahn, ... Jama 316 (10), 1093-1103, 2016 | 2602 | 2016 |
| Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold PJ Neumann, JT Cohen, MC Weinstein N Engl J Med 371 (9), 796-797, 2014 | 2169 | 2014 |
| Long-term persistence in use of statin therapy in elderly patients JS Benner, RJ Glynn, H Mogun, PJ Neumann, MC Weinstein, J Avorn Jama 288 (4), 455-461, 2002 | 1597 | 2002 |
| Cost-effectiveness in health and medicine PJ Neumann, GD Sanders, LB Russell, JE Siegel, TG Ganiats Oxford University Press, 2016 | 1239 | 2016 |
| Using real‐world data for coverage and payment decisions: the ISPOR real‐world data task force report LP Garrison Jr, PJ Neumann, P Erickson, D Marshall, CD Mullins Value in health 10 (5), 326-335, 2007 | 800 | 2007 |
| Does preventive care save money? Health economics and the presidential candidates JT Cohen, PJ Neumann, MC Weinstein New England Journal of Medicine 358 (7), 661-663, 2008 | 667 | 2008 |
| Key principles for the improved conduct of health technology assessments for resource allocation decisions MF Drummond, JS Schwartz, B Jönsson, BR Luce, PJ Neumann, ... International journal of technology assessment in health care 24 (3), 244-258, 2008 | 639 | 2008 |
| Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States JA Doshi, P Hodgkins, J Kahle, V Sikirica, MJ Cangelosi, J Setyawan, ... Journal of the American Academy of Child & Adolescent Psychiatry 51 (10 …, 2012 | 562 | 2012 |
| Bias in published cost effectiveness studies: systematic review CM Bell, DR Urbach, JG Ray, A Bayoumi, AB Rosen, D Greenberg, ... Bmj 332 (7543), 699-703, 2006 | 434 | 2006 |
| Examining the value and quality of health economic analyses: implications of utilizing the QHES JJ Ofman, SD Sullivan, PJ Neumann, CF Chiou, JM Henning, SW Wade, ... Journal of Managed Care Pharmacy 9 (1), 53-61, 2003 | 407 | 2003 |
| Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers JJ Carlson, SD Sullivan, LP Garrison, PJ Neumann, DL Veenstra Health policy 96 (3), 179-190, 2010 | 371 | 2010 |
| Prevalence and impact of medical comorbidity in Alzheimer's disease PM Doraiswamy, J Leon, JL Cummings, D Marin, PJ Neumann The Journals of Gerontology Series A: Biological Sciences and Medical …, 2002 | 361 | 2002 |
| Preference-based measures in economic evaluation in health care PJ Neumann, SJ Goldie, MC Weinstein Annual review of public health 21 (1), 587-611, 2000 | 361 | 2000 |
| Development and validation of a grading system for the quality of cost-effectiveness studies CF Chiou, JW Hay, JF Wallace, BS Bloom, PJ Neumann, SD Sullivan, ... Medical care 41 (1), 32-44, 2003 | 359 | 2003 |
| Systematic overview of cost-utility assessments in oncology CC Earle, RH Chapman, CS Baker, CM Bell, PW Stone, EA Sandberg, ... Journal of Clinical Oncology 18 (18), 3302-3317, 2000 | 337 | 2000 |
| Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis CC Earle, JS Tsai, RD Gelber, MC Weinstein, PJ Neumann, JC Weeks Journal of Clinical Oncology 19 (4), 1064-1070, 2001 | 329 | 2001 |
| The use of proxy respondents in studies of older adults: lessons, challenges, and opportunities PJ Neumann, SS Araki, EM Gutterman Journal of the American Geriatrics Society 48 (12), 1646-1654, 2000 | 315 | 2000 |
| Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease PJ Neumann, RC Hermann, KM Kuntz, SS Araki, SB Duff, J Leon, ... Neurology 52 (6), 1138-1138, 1999 | 313 | 1999 |
| A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial RH Reindollar, MM Regan, PJ Neumann, BS Levine, KL Thornton, ... Fertility and sterility 94 (3), 888-899, 2010 | 309 | 2010 |
| Legislating against use of cost-effectiveness information PJ Neumann, MC Weinstein N Engl J Med 363 (16), 1495-1497, 2010 | 295 | 2010 |
James ChambersAssociate Professor Center for the Evaluation of Value and Risk in Health at Tufts Medical Center在 tuftsmedicalcenter.org 的电子邮件经过验证
